Keywords: jprd, completes, zarnestra, nda, usa-based, johnson, pharmaceutical

J&JPRD completes Zarnestra NDA

Article | 07 February 2005

USA-based Johnson & Johnson Pharmaceutical Research & Development has completed the submission of a New Drug Application for its anticancer candidate Zarnestra ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Johnson & Johnson

Go to company listing